The dramatic inhibition of tumor numbers and weight by lentivirus-mediated Nogo-B downregulation in a HFHC-induced HCC model further establishes the strong oncogenic activity of Nogo-B during NAFLD progression. Here, RTN4 is linked to metabolic dysfunction-associated steatotic liver disease.